{"id":"W2810901052","doi":"10.1158/1538-7445.am2018-1209","title":"Abstract 1209: Patterns of treatment with immune check point inhibitors and targeted therapy in patients with metastatic melanoma presumed BRAF V600 positive","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Ipilimumab; Pembrolizumab; Dabrafenib; Vemurafenib; Nivolumab; Trametinib; Internal medicine; Metastatic melanoma; Oncology; Melanoma; Targeted therapy; Combination therapy; Cancer; Immunotherapy; Cancer research; Kinase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004803808,0.0001487349,0.0002994544,0.001141635,0.0003809121,0.0006114822,0.0004538967,0.0003332851,0.00278311],"category_scores_gemma":[0.002631694,0.0001527469,0.000479464,0.001984148,0.0002188169,0.0005322077,0.0005428958,0.0005548534,0.000432861],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007162716,"about_ca_system_score_gemma":0.0006679734,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00835212,"about_ca_topic_score_gemma":0.01059674,"domain_scores_codex":[0.9991831,0.0001313559,0.0001618604,0.0002388251,0.0001526096,0.000132219],"domain_scores_gemma":[0.9966269,0.0003702357,0.002401463,0.00008658379,0.0002230624,0.0002918427],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001234537,0.00002124846,0.9974281,0.00001903681,0.00001941033,0.000071921,0.00006722623,0.00002594696,0.000139714,0.00001581683,0.0002632649,0.001804818],"study_design_scores_gemma":[0.000007970353,0.00008783755,0.998317,0.00002107363,0.00001451129,0.000459093,0.0003112817,0.0001667503,0.00009961836,0.00001964357,0.0004912814,0.00000393372],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960015,0.0004700792,0.00007148004,0.0001278284,0.000004447425,0.00001795781,0.002514841,0.000006010421,0.0007857423],"genre_scores_gemma":[0.9978145,0.0001998828,0.0001132945,0.00007436797,0.000009400432,0.00001557635,0.001590895,0.00000432677,0.0001777635],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00835212,"threshold_uncertainty_score":0.01660705,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03087817458581507,"score_gpt":0.3388851747655651,"score_spread":0.30800700017975,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}